ArticleMateria socio-medica2025
Quality of Life of Patients After Nasal Septoplasty.
Article in Materia socio-medica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nasal obstruction was a common symptom encountered in otolaryngology, arising from various etiologies, including both mucosal and structural factors. Objective: The aim of this study was to evaluate the quality of life of patients after nasal septoplasty. Methods: A prospective, longitudinal 6-month study was conducted on 52 patients who underwent septoplasty or rhinoplasty and were followed up at Hanoi Medical University Hospital from April 2023 to April 2024. The effectiveness of the surgery was assessed through clinical nasal symptoms, and the quality of life of patients was evaluated using the SF-36 Quality of Life Assessment Tool (Short Form-36). Results: In the study group, 27 (51.9%) patients were female. The nasal obstruction scores significantly decreased from preoperative (2.67 ± 0.47) to 1 month (1.1 ± 0.75) and 6 months (0.65 ± 0.68) postoperative (p<0.05). The facial pain scores significantly decreased from preoperative (1.46 ± 1.11) to 1 month (1.1 ± 1.05) and 6 months (0.79 ± 0.89) postoperative (p<0.05). The rhinitis scores significantly decreased from preoperative (1.42 ± 1.11) to 1 month (1.02 ± 1) and 6 months (0.77 ± 0.9) postoperative (p<0.05). The average quality of life scores according to the 8 factors of the SF-36 Quality of Life Assessment Tool increased at 1 month and 6 months postoperative. The differences were statistically significant (p<0.05). Conclusion: Nasal septoplasty significantly improves clinical symptoms and the quality of life of patients. The SF-36 is a reliable outcome measure for the success of nasal septal surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.